Table 4:

One-way sensitivity analysis results: probability of cataract^a

Probability of Cataract	Strategy	Cost ($)	Effectiveness (QALYs)	Incremental Cost ($)	Incremental Effectiveness (QALYs)	Incremental Cost-Effectiveness Ratio ($/QALY)
0	CTAP	147,110	13.81	0	0
0	TCD	154,719	13.62	7608.40	−0.20	Dominated
0.2	CTAP	147,625	13.80	0	0
0.2	TCD	154,719	13.62	7094.12	−0.18	Dominated
0.4	CTAP	148,139	13.78	0	0
0.4	TCD	154,719	13.62	6579.84	−0.17	Dominated
0.6	CTAP	148,653	13.77	0	0
0.6	TCD	154,719	13.62	6065.56	−0.15	Dominated
0.8	CTAP	149,168	13.75	0	0
0.8	TCD	154,719	13.62	5551.28	−0.13	Dominated
1	CTAP	149,682	13.73	0	0
1	TCD	154,719	13.62	5037.00	−0.12	Dominated

^aIn a 1-way sensitivity analysis, CTAP remained the optimal strategy when varying the probability of cataract from 0.0 to 1.0.